Ignite Creation Date:
2024-05-06 @ 3:14 AM
Last Modification Date:
2024-10-26 @ 11:30 AM
Study NCT ID:
NCT02230228
Status:
COMPLETED
Last Update Posted:
2015-03-24
First Post:
2014-08-27
Brief Title:
Phase 1 Safety Study of ALK-001 in Healthy Volunteers
Sponsor:
Alkeus Pharmaceuticals Inc
Organization:
Alkeus Pharmaceuticals Inc
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Other Retinal Dystrophies |
| Stargardt Disease |
| Age-related Macular Degeneration |
Keywords: